Skip to main content
. 2021 Aug 17;8:711823. doi: 10.3389/fmed.2021.711823

Figure 1.

Figure 1

Schematic overview of preclinical and clinical molecular (B) and clinical alterations (C) in psoriatic arthritis in humans and the featured mice models (A) for psoriatic arthritis. PsO, psoriasis; IL, interleukin; IFN, interferon; GCSF, granulocyte colony-stimulating factor; CXCL, chemokine ligand; STAT, signal transducer and activator of transcription; Th, T helper cells; DAMP, danger associated molecular patterns; CD, cluster of differentiation; Tc, cytotoxic T cells; TNF, tumor necrosis factor; PsA, psoriatic arthritis. Figure created with BioRender.com.